Analysis of Pharmaceutical Reimbursement Policy Reforms by Actor-Centered Institutionalism: In Case of Positive-list System and Risk Sharing Agreement
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI